According to PA Consulting’s Jan Malek, R&D president isn’t one job – it’s two. Maybe it’s time to create a new position …
Karl Yorgey works with the GPCD in the pre-clinical organization for Johnson & Johnson, supporting all of the GLP applications within preclinical. Thermo Electron Corporation’s LIMS, Watson, is one such application.
Molecular therapeutics that target proteins kinases represent a major advance in the treatment of disease, particularly cancer.
Robust calcium mobilization by a broad range of overexpressed GPCRs in cell lines containing endogenous promiscuous G proteins
Universal HTRF lipid kinase and STK assays.